Medigard is an innovative international company that specialises in retractable safety medical devices for the global market.

A future-thinking, results-driven company, Medigard believes in plain talk and practical solutions to complex problems.

Our unique platform technology has enabled Medigard to create a range of medical devices that are safer, more affordable and more efficient than our competitors’.

Medigard’s expertise lies in our ability to source, design and develop medical devices within a small, robust and adaptable environment. We deliver maximum efficiency with minimal cost.

 

LATEST NEWS

Innovative Australian medical device company Medigard has today announced that it will offer its existing shareholders a Renounceable Rights Issue to support its expansion into the US. Medigard will offer existing shareholders 74,046,091 new shares at an issue price of 6.5 cents. As part of the offer, each new share will have an attached option, exercisable at 9.5 cents on or before 30 June 2011. Read more.